Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial
Filip van den Bosch,
Vibeke Strand,
Cunshan Wang,
Joseph C Cappelleri,
Joseph Wu,
Marina Magrey,
James Cheng-Chung Wei,
Victoria Navarro-Compán,
Lisy Wang,
Lara Fallon,
Dona Fleishaker,
Oluwaseyi Dina
Affiliations
Filip van den Bosch
Department of Rheumatology, Ghent University, VIB Center for Inflammation Research, Gent, Belgium
Vibeke Strand
Immunology/Rheumatology, Stanford University, Stanford, California, USA
Cunshan Wang
6 Global Product Development, Pfizer Inc, Groton, Connecticut, USA
Joseph C Cappelleri
Global Research and Development, Pfizer Inc, Groton, Connecticut, USA
Joseph Wu
6 Global Product Development, Pfizer Inc, Groton, Connecticut, USA
Marina Magrey
School of Medicine at Metrohealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA
James Cheng-Chung Wei
3 Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan
Victoria Navarro-Compán
Rheumatology, La Paz University Hospital, Madrid, Spain
Lisy Wang
4 Pfizer Inc, Groton, Connecticut, USA
Lara Fallon
Global Medical Affairs, Rheumatology, Pfizer Inc, Kirkland, Quebec, Canada
Dona Fleishaker
6 Global Product Development, Pfizer Inc, Groton, Connecticut, USA
Oluwaseyi Dina
7 Health Economics and Outcomes Research, Pfizer Inc, New York, New York, USA
